Metered-dose inhalers
This article was originally published in The Tan Sheet
Executive Summary
FDA's Generic Drugs Advisory Committee will discuss results of bioequivalence studies of metered-dose inhalers conducted by Johns Hopkins University on the first day of a meeting tentatively set for Sept. 14-15. FDA had hoped to bring the studies before the committee in June. On the second day, the committee will address issues related to documentation of bioequivalence for solution/device combinations. The meeting is expected to be held at the Potomac Inn in Rockville, Md.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning